Correlation Between Fate Therapeutics and Vigil Neuroscience
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Vigil Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Vigil Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Vigil Neuroscience, you can compare the effects of market volatilities on Fate Therapeutics and Vigil Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Vigil Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Vigil Neuroscience.
Diversification Opportunities for Fate Therapeutics and Vigil Neuroscience
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Fate and Vigil is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Vigil Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vigil Neuroscience and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Vigil Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vigil Neuroscience has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Vigil Neuroscience go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Vigil Neuroscience
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Vigil Neuroscience. But the stock apears to be less risky and, when comparing its historical volatility, Fate Therapeutics is 1.17 times less risky than Vigil Neuroscience. The stock trades about -0.03 of its potential returns per unit of risk. The Vigil Neuroscience is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1,020 in Vigil Neuroscience on December 8, 2024 and sell it today you would lose (770.00) from holding Vigil Neuroscience or give up 75.49% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Vigil Neuroscience
Performance |
Timeline |
Fate Therapeutics |
Vigil Neuroscience |
Fate Therapeutics and Vigil Neuroscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Vigil Neuroscience
The main advantage of trading using opposite Fate Therapeutics and Vigil Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Vigil Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vigil Neuroscience will offset losses from the drop in Vigil Neuroscience's long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Vigil Neuroscience vs. Molecular Partners AG | Vigil Neuroscience vs. Pmv Pharmaceuticals | Vigil Neuroscience vs. Monte Rosa Therapeutics | Vigil Neuroscience vs. Entrada Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |